https://www.selleckchem.com/products/fsen1.html
Originally developed for predicting the risk of stroke in patients with atrial fibrillation (AF), the CHA DS -VASc score also has the potential to predict the risk of other cardiovascular disease. This study aimed to investigate the prognostic value of the CHA DS -VASc score in patients with peripheral artery disease (PAD) requiring Femoral popliteal (FP) endovascular therapy (EVT). This multicenter, retrospective study analyzed the clinical database of 2190 patients who underwent FP EVT for symptomatic PAD (Rutherford categories 2-4) bet
Like
Comment
Share
